Search

Your search keyword '"Comparato G"' showing total 119 results
Start Over Author "Comparato G"
119 results on '"Comparato G"'

3. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

Author

Mascolo, M.C., Cursaro, C., Scuteri, A., Ranieri, J., Monti, M., Bellentani, S., Gasbarrini, A., Pompili, M., Puoti, C., Bellis, L., Regazzetti, A., Maffezzini, E., Pietrangelo, A., Abbati, G., Raimondo, G., Scribano, L., Martines, D., Baroni, G. Svegliati, Faraci, G., Schianchi, S., Fornaciari, G., Fabris, P., Madonia, S., Civitavecchia, G., Pirisi, M., Smirne, C., Borghi, A., Sardini, C., Andreoletti, M., Morisco, F., Caporaso, N., Fargion, S., Fatta, E., Masutti, F., Bonaventura, M.E., Autolitano, A., Russello, M., Bellia, A., Toniutto, P., Bitetto, D., Mecenate, F., Pasulo, L., Lucà, M.G., Picardi, A., Vespasiani, U., Grattagliano, I., Palasciano, G., Romagno, D., Crespi, C., Gianstefani, A., Gobbo, G., Monti, V., Giannelli, G., Napoli, N., Nosotti, Raspanti, A., Cuccorese, Colombo, A.E., Floridia, Plattella, M.S., Cassano, P., Gentile, I., Blanc, P.L., Messina, V., Bonfante, S., Bellissima, P., Toti, M., Vecchiet, J., Falasca, K., Portelli, V., De Stefano, G., Pietromatera, G., Viganò, P., Re, T., Andreoni, M., Raineri, G., Massari, M., Grossi, P.A., Caputo, S., Cassola, G., Feasi, M., Foti, G., Kunkar, A., Corti, G., Baragli, F., Caterini, L., Migliorini, D., Chiodera, A., Calleri, G., Spezia, C., Baiguera, C., Puoti, M., Brancaccio, G., Gaeta, G.B., Vento, S., Di Biagio, A., Nicolini, L., Liberti, A., Iannece, M.D., Contini, C., Tacconi, D., Caremani, M., Almi, P., Chimenti, M., Cosco, Messeri, D., Esperti, F.C., Paffetti, A., Mastropietro, C., Moretti, A., Spagnolo, A.L., Lomonaco, L., Calì, A., Mandelli, G., Spinzi, G.C., Framarin, L., Berrutti, M., Boccia, S., Simone, L., Pazzi, P., Fornari, F., Comparato, G., Casetti, T., Foschi, F.G., Bertin, T., Salvagnini, M., Samori, A., Ferretti, E., Casiraghi, M.A., Marin, R., Ciancio, A., Campo, N., Testa, R., Rocco, A., Federico, A., Loguercio, C., Rizzo, S., Giannini, E.G., Corbo, M., Riegler, G., Esposito, P., Ricci, G.L., Rosina, Floriano, Tosti, Maria Elena, Borghesio, Elisabetta, Masocco, Maria, Mele, Alfonso, Coppola, Carmine, Milella, Michele, Borgia, Guglielmo, Andreone, Pietro, Koch, Maurizio, Zignego, Anna Linda, Romano, Mario, Carrara, Maurizio, Almasio, Piero Luigi, Azzola, Emilio, Nardone, Gerardo, Benedetti, Antonio, Carosi, Giampiero, Mazzotta, Francesco, Sagnelli, Evangelista, and Rizzetto, Mario

Published
2014
Full Text
View/download PDF

9. Bovine lactoferrin for Helicobacter pylori eradication: an open, randomized, multicentre study

Author

DI MARIO, F., ARAGONA, G., DAL BÓ, N., CAVALLARO, L., MARCON, V., OLIVIERI, P., BENEDETTI, E., ORZÈS, N., MARIN, R., TAFNER, G., CHILOVI, F., DE BASTIANI, R., FEDRIZZI, F., FRANCESCHI, M., SALVAT, M. H., MONICA, F., PIAZZI, L., VALIANTE, F., VECCHIATI, U., CAVESTRO, G. M., COMPARATO, G., IORI, V., MAINO, M., LEANDRO, G., PILOTTO, A., RUGGE, M., and FRANZÈ, A.

Published
2006

15. Pegylated interferon α plus ribavirin for the treatment of chronic hepatitis C: A multicentre independent study supported by the Italian Drug Agency

Author

Rosina, Floriano, Tosti, Maria Elena, Borghesio, Elisabetta, Masocco, Maria, Mele, Alfonso, Coppola, Carmine, Milella, Michele, Borgia, Guglielmo, Andreone, Pietro, Koch, Maurizio, Zignego, Anna Linda, Romano, Mario, Carrara, Maurizio, Almasio, Piero Luigi, Azzola, Emilio, Nardone, Gerardo, Benedetti, Antonio, Carosi, Giampiero, Mazzotta, Francesco, Sagnelli, Evangelista, Rizzetto, Mario, Mascolo, M. C., Cursaro, C., Scuteri, A., Crespi, C., Gianstefani, A., Ranieri, J., Monti, M., Corti, G., Blanc, P. L., Baragli, F., Bellentani, S., Gasbarrini, A., Pompili, M., Mecenate, F., Picardi, A., Vespasiani, U., Nosotti, Null, Null, A. Picardi, Ricci, G. L., Paffetti, A., Mastropietro, C., Moretti, A., Spagnolo, A. L., Puoti, C., Bellis, L., Regazzetti, A., Maffezzini, E., Pietrangelo, A., Abbati, G., Borghi, A., Sardini, C., Raimondo, G., Scribano, L., Martines, D., Svegliati Baroni, G., Faraci, G., Schi anchi, S., Fornaciari, G., Massari, M., Fabris, P., Bertin, T., Salvagnini, M., Madonia, S., Calì, A., Civitavecchia, G., Pirisi, M., Smirne, C., Andreoletti, M., Morisco, F., Caporaso, N., Gentile, I., Brancaccio, G., Gaeta, G. B., Liberti, A., Iannece, M. D., Rocco, A., Federico, A., Loguercio, C., Riegler, G., Esposito, P., Fargion, S., Fatta, E., Masutti, F., Bonaventura, M. E., Autolitano, A., Russello, M., Bellia, A., Toniutto, P., Bitetto, D., Pasulo, L., Lucà, M. G., Grattagliano, I., Palasciano, G., Romagno, D., Giannelli, G., Napoli, N., Plattella, M. S., Cassano, P., Gobbo, G., Monti, V., Raspanti, A., Cuccorese, Null, Colombo, A. E., Mandelli, G., Spinzi, G. C., Floridia, Null, Messina, V., Bonfante, S., Bellissima, P., Toti, M., Vecchiet, J., Falasca, K., Portelli, V., Stefano, G. De, Pietromatera, G., Viganò, P., Re, T., Andreoni, M., Null, G. Raineri, Grossi, P. A., Caputo, S., Cassola, G., Feasi, M., Biagio, A. Di, Nicolini, LAURA AMBRA, Giannini, EDOARDO GIOVANNI, Corbo, M., Foti, G., Kunkar, A., Caterini, L., Migliorini, D., Chiodera, A., Calleri, G., Spezia, C., Framarin, L., Null, M. Berrutti, Ciancio, A., Baiguera, C., Puoti, M., Vento, S., Contini, C., Boccia, S., Casiraghi, M. A., Simone, L., Tacconi, D., Caremani, M., Almi, P., Chimenti, M., Cosco, Null, Messeri, D., Esperti, F. C., Lomonaco, L., Pazzi, P., Fornari, F., Comparato, G., Casetti, T., Foschi, F. G., Samori, A., Ferretti, E., Marin, R., Campo, N., Testa, R., Rizzo, S., Rosina, F, Tosti, ME, Borghesio, E, Masocco, M, Mele, A, Coppola, C, Milella, M, Borgia, G, Andreone, P, Koch, M, Zignego, AL, Romano, M, Carrara, M, Almasio, PL, Azzola, E, Nardone, G, Benedetti, A, Carosi, G, Mazzotta, F, Sagnelli, E, Rizzetto, M, Rosina, F., Tosti, M. E., Borghesio, E., Masocco, M., Mele, A., Coppola, C., Milella, M., Borgia, Guglielmo, Andreone, P., Koch, M., Zignego, A. L., Romano, M., Carrara, M., Almasio, P. L., Azzola, E., Nardone, GERARDO ANTONIO PIO, Benedetti, A., Carosi, G., Mazzotta, F., Sagnelli, E., Rizzetto, M., Aifa, Aisf, Simit, Aigo, Sige, Gentile, Ivan, Morisco, Filomena, Et, Al, Floriano Rosina, Maria Elena Tosti, Elisabetta Borghesio, Maria Masocco, Alfonso Mele, Carmine Coppola, Michele Milella, Guglielmo Borgia, Pietro Andreone, Maurizio Koch, Anna Linda Zignego, Mario Romano, Maurizio Carrara, Piero Luigi Almasio, Emilio Azzola, Gerardo Nardone, Antonio Benedetti, Giampiero Carosi, Francesco Mazzotta, Evangelista Sagnelli, and Mario Rizzetto

Subjects
Registrie, Male, Cirrhosis, medicine.disease_cause, Polyethylene Glycol, Gastroenterology, Polyethylene Glycols, chemistry.chemical_compound, Hepatitis Viruses, Hepatitis Viruse, Prospective Studies, Viral, Registries, Chronic, Prospective cohort study, Drug Carrier, Drug Carriers, Settore MED/12 - Gastroenterologia, Medicine (all), Recombinant Protein, Middle Aged, Hepatitis C, Recombinant Proteins, Treatment Outcome, Italy, Combination, RNA, Viral, Population study, Drug Therapy, Combination, Female, Human, medicine.medical_specialty, Genotype, Hepatitis C virus, Alpha interferon, Ribavirin, Sustained virological response (SVR), Treatment, Antiviral Agents, Follow-Up Studie, Hepatology, Drug Therapy, Internal medicine, medicine, Humans, Antiviral Agent, business.industry, Interferon-alpha, HCV therapy, Hepatitis C, Chronic, medicine.disease, Clinical trial, Prospective Studie, chemistry, Immunology, RNA, Follow-Up Studies, business
Abstract

a b s t r a c t Background: Data on the efficacy of Peg-interferon/ribavirin therapy for chronic hepatitis C are mostly derived from treatment of selected patients enrolled in clinical trials. This study aimed to assess the effectiveness of Peg-interferon/ribavirin therapy in “real world” chronic hepatitis C patients in Italy. Methods: Independent observational multicentre study including consecutive patients receiving Peginterferon/ribavirin in the 18 months before (retrospective phase) and after (prospective phase) the start of the study. Results: 4176 patients were eligible. The final study population consisted of 2051 patients in the retrospective and 2073 in the prospective phase. Sustained virological response was achieved by 1036 patients (50.5%) during the retrospective phase: 325 were genotypes 1/4 (34.1%) and 684 were genotypes 2/3 (67.2%) and by 800 patients (38.6%) during the prospective phase: 300 were genotypes 1/4 (28.4%) and 473 were genotypes 2/3 (51.5%). During multivariate analysis genotypes 2/3 were significantly associated with higher sustained virological response rates; cirrhosis and -glutamil-transpeptidase >2 times the normal limit were associated with poorer response. Conclusions: The response to Peg-interferon/ribavirin therapy in “real world” clinical practice is distinctly lower than in registration trials. The difference in response rates was more pronounced among easy-totreat than among difficult-to-treat hepatitis C virus genotypes.

Published
2014

18. Usefulness of a serological panel test in the assessment of gastritis in symptomatic children

Author

de Angelis GL, Cavallaro LG, Maffini V, Moussa AM, Fornaroli F, Liatopoulou S, Bizzarri B, Merli R, Comparato G, Caruana P, Franzé A, Di Mario F., CAVESTRO , GIULIA MARTINA, de Angelis, Gl, Cavallaro, Lg, Maffini, V, Moussa, Am, Fornaroli, F, Liatopoulou, S, Bizzarri, B, Merli, R, Comparato, G, Caruana, P, Cavestro, GIULIA MARTINA, Franzé, A, and Di Mario, F.

Published
2007

20. Use of mesalazine in diverticular disease

Author

Di Mario F, Comparato G, Fanigliulo L, Aragona G, Cavallaro LG, Franzé A., CAVESTRO , GIULIA MARTINA, Di Mario, F, Comparato, G, Fanigliulo, L, Aragona, G, Cavallaro, Lg, Cavestro, GIULIA MARTINA, and Franzé, A.

Published
2006

21. Efficacy of mesalazine in the treatment of symptomatic diverticular disease

Author

Di Mario F, Aragona G, Leandro G, Comparato G, Fanigliulo L, Cavallaro LG, Iori V, Maino M, Moussa AM, Gnocchi A, Mazzocchi G, Franzé A., CAVESTRO , GIULIA MARTINA, Di Mario, F, Aragona, G, Leandro, G, Comparato, G, Fanigliulo, L, Cavallaro, Lg, Cavestro, GIULIA MARTINA, Iori, V, Maino, M, Moussa, Am, Gnocchi, A, Mazzocchi, G, and Franzé, A.

Published
2005

23. Genetics of chronic pancreatitis

Author

Cavestro, G. M., Comparato, G., Antonio Nouvenne, Sereni, G., Bertolini, S., Frulloni, L., Dalla Valle, R., Soliani, P., Zanelli, P. F., Sianesi, M., Franzè, A., Di Mario, F., Cavestro, GIULIA MARTINA, Comparato, G, Nouvenne, A, Sereni, G, Bertolini, S, Frulloni, L, Dalla Valle, R, Soliani, P, Zanelli, Pf, Sianesi, M, Franzè, A, and Di Mario, F.

Published
2005

24. Prevalence of H. pylori CagA+ve in suburban area with high incidence of gastric cancer

Author

FRANZ A, NERVI G, COMPARATO G, MOUSSA AM, DE LISI V, CARLONI C, LIATOPOULOU S, ARAGONA G, CAVALLARO LG, IORI V, MAINO M, MARCUCCI F, DI MARIO F., CAVESTRO , GIULIA MARTINA, Franz, A, Nervi, G, Comparato, G, Moussa, Am, DE LISI, V, Carloni, C, Liatopoulou, S, Aragona, G, Cavallaro, Lg, Cavestro, GIULIA MARTINA, Iori, V, Maino, M, Marcucci, F, and DI MARIO, F.

Published
2003

25. Lactoferrin in a 1-week triple therapy for eradication of H. pylori

Author

ARAGONA G, DI MARIO F, CAVALLARO GL, IORI V, COMPARATO G, LEANDRO G, MUZZETTO P, PILOTTO A, FRANZ A., CAVESTRO , GIULIA MARTINA, Aragona, G, DI MARIO, F, Cavallaro, Gl, Cavestro, GIULIA MARTINA, Iori, V, Comparato, G, Leandro, G, Muzzetto, P, Pilotto, A, and Franz, A.

Published
2003

27. Prevalence of CagA status in an high risk area for gastric carcinoma

Author

FRANZ A, NERVI G, COMPARATO G, MOUSSA AM, DE LISI V, DI COLA G, CARLONI C, LIATOPOLOU S, CAVALLARO LG, IORI V, DI MARIO F., CAVESTRO , GIULIA MARTINA, Franz, A, Nervi, G, Comparato, G, Moussa, Am, DE LISI, V, DI COLA, G, Carloni, C, Liatopolou, S, Cavallaro, Lg, Cavestro, GIULIA MARTINA, Iori, V, and DI MARIO, F.

Published
2003

28. Gastropanel as screening of gastric atrophy in primary care

Author

GERMANA B, LIATOPOULOU S, COMPARATO G, MOUSSA AM, CARLONI C, LECIS P, BERTIATO B, DOGLIONI C, ARAGONA G, CAVALLARO LG, IORI V, MERLI R, BERTOLINI S, CARUANA P, BIEDO FC, DI MARIO F., CAVESTRO , GIULIA MARTINA, Germana, B, Liatopoulou, S, Comparato, G, Moussa, Am, Carloni, C, Lecis, P, Bertiato, B, Doglioni, C, Aragona, G, Cavallaro, Lg, Cavestro, GIULIA MARTINA, Iori, V, Merli, R, Bertolini, S, Caruana, P, Biedo, Fc, and DI MARIO, F.

Published
2003

31. Relationship between direct and indirect methods for diagnosis of H.pylori infection

Author

MOUSSA A, IORI V, ARAGONA G, SEGHINI P, CERATI E, CAMPI L, COMPARATO G, LEANDRO G, BATTAGLIA G, DAL B. N, FRANZ A, DI MARIO F., CAVESTRO , GIULIA MARTINA, Moussa, A, Iori, V, Aragona, G, Seghini, P, Cerati, E, Campi, L, Cavestro, GIULIA MARTINA, Comparato, G, Leandro, G, Battaglia, G, DAL B., N, Franz, A, and DI MARIO, F.

Published
2002

32. The Long Shadow of the Volksgeist. Or: the Nationalist Dimension in European Private Law Discourse

Author

Comparato, G. and CSECL (FdR)

Abstract

The paper aims at unfolding the ideological underpinnings and the cultural-historical foundations of one of the latent basic assumptions of modern legal scholarship, which is the link between private law and the national idea. In particular processes of denationalisation triggered by European integration have led to resistance from Member States and a defense of the idea that law should remain national. This link is often ideally justified by the view that law is an expression of the cultural values embedded in the nation, which can be termed ‘Volksgeist’ theory. This particular view, which has long historical roots but is mainly entangled with the ideology of cultural nationalism, has now become generally accepted, albeit in a disguised form, in modern political and legal discourse. Combining insights from legal and political studies, the paper traces the circumstances that led to the affirmation of the national idea in private law, tracking that idea in legal history, in political theory and finally legal scholarship. It asserts that, notwithstanding the historical defeat of the most notorious manifestations of nationalism, several assumptions of cultural nationalism have become commonly accepted and can still be detected in the legal discourse.

Published
2012

33. Nationalism and private law in Europe

Author

Comparato, G., Hesselink, Martijn, Mak, Chantal, and CSECL (FdR)

Abstract

Een aantal argumenten tegen de Europeanisering van het privaatrecht blijkt gebaseerd te zijn op stilzwijgend nationalistische veronderstellingen. Deze veronderstellingen kunnen niet alleen worden gebruikt om bezwaar te maken tegen processen van denationalisering, maar ook om ze te bevorderen. Dit stelt Guido Comparato in zijn proefschrift. Hij beschrijft het conceptuele en historische verband tussen privaatrecht en nationalisme, en onderzoekt de vraag in hoeverre nationalisme nog een rol kan spelen in het proces van Europeanisering van het privaatrecht. In het debat over de Europeanisering van het privaatrecht zijn er juristen die beargumenteren dat dit niet haalbaar of wenselijk is, aangezien het geen respect zou tonen voor culturele verschillen die typisch nationaal zijn en die in de nationale wetgeving zijn weerspiegeld. Europees privaatrecht zou daardoor geen rekening kunnen houden met de verschillende culturen, ideeën over het begrip van rechtvaardigheid en economische voorkeuren die mensen in verschillende naties hebben. Uit het onderzoek Methodologisch nationalistische argumenten kunnen echter niet alleen worden gebruikt om bezwaar te maken tegen processen van denationalisering, maar ook om ze te bevorderen. De strategieën van natievorming die werden gebruikt om een nationaal bewustzijn te verspreiden, zouden kunnen worden herhaald op Europees niveau om een soort van ‘Europese identiteit’ te laten bloeien. Comparato betoogt dat niet kan worden uitgesloten dat ook het privaatrecht een rol kan spelen in de bevordering van een coll

Published
2012

38. OC.03.5 ECHOGRAPHIC DETECTION OF HEPATOCELLULAR CARCINOMA (HCC) DURING FOLLOW UP IN CIRRHOTIC PATIENTS WITH PREVIOUS HCC. COMPARISON AMONG US, CT AND A NEW PANORAMIC 3-DIMENSIONAL CONTRAST-ENHANCED US WITH NAVIGATOR SYSTEM (3-D NAV CEUS)

Author

Giangregorio, F., primary, Marinone, M., additional, Aragona, G., additional, Comparato, G., additional, Fanigliulo, L., additional, Sbolli, G., additional, Di Stasi, M., additional, Tansini, P., additional, and Fornari, F., additional

Published
2010
Full Text
View/download PDF

42. CS1.1 EFFICACY OF MESALAMINE AND THE ASSOCIATION OF MESALAMINE AND PROBIOTICS VERSUS RIFAXIMIN IN THE TREATMENT OF SYMPTOMATIC DIVERTICULAR DISEASE

Author

Curlo, M., primary, Fanigliulo, L., additional, Comparato, G., additional, Aragona, G., additional, Cavallaro, L.G., additional, Altavilla, N., additional, Bacchin, P., additional, Dal Bò, N., additional, De Bastiani, R., additional, Fedrizzi, F., additional, Marcon, V., additional, Marin, R., additional, Tafner, G., additional, Franzè, A., additional, and Di Mario, F., additional

Published
2008
Full Text
View/download PDF

43. OC2.01.6 ECHOGRAPHIC DETECTION OF NEW HCCS IN CIRRHOTIC PATIENTS (PREVIOUSLY TREATED WITH MULTIPLE TECHNIQUES): COMPARISON AMONG CONVENTIONAL US, SPIRAL CT AND 3-DIMENSIONAL CONTRAST-ENHANCED US WITH NAVIGATOR TECHNIQUE (3DNAV CEUS)

Author

Giangregorio, F., primary, Comparato, G., additional, Fanigiulo, L., additional, Sbolli, G., additional, Di Stasi, M., additional, Marinone, G., additional, Tansini, P., additional, Aragona, G., additional, and Fornari, F., additional

Published
2008
Full Text
View/download PDF

45. PA.61 DIVERTICULAR DISEASE OF THE COLON IN PARMA AREA: THE EPIDEMIOLOGY IN A PRIMARY CARE SETTING

Author

Campanini, A., primary, Curlo, M., additional, Guida, L., additional, Carosino, C., additional, Corchia, P., additional, Fellon, D., additional, Gardini, L., additional, Gorreri, O., additional, Mezzadri, P., additional, Molinari, B., additional, Ronchini, P., additional, Scali, M., additional, Schianchi, P., additional, Comparato, G., additional, Fanigliulo, L., additional, Franzè, A., additional, and Di Mario, F., additional

Published
2008
Full Text
View/download PDF

47. ROLE OF FAECAL ELASTASE 1 IN PANCREATIC CANCER: A PILOT STUDY.

Author

Cavestro, G.M., primary, Nouvenne, A., additional, Merli, R., additional, Comparato, G., additional, Leandro, G., additional, Corrente, V., additional, Valle, R. Dalla, additional, Soliani, P., additional, Sianesi, M., additional, Franzè, A., additional, and Di Mario, F., additional

Published
2004
Full Text
View/download PDF

49. Clinical usefulness of serum pepsinogens I and II, gastrin-17 and anti-Helicobacter pylori antibodies in the management of dyspeptic patients in primary care.

Author

Germaná, B., Di Mario, F., Cavallaro, L.G., Moussa, A.M., Lecis, P., Liatoupolou, S., Comparato, G., Carloni, C., Bertiato, G., Battiestel, M., Papa, N., Aragona, G., Cavestro, G.M., Iori, V., Merli, R., Bertolini, S., Caruana, P., and Franzé, A.

Subjects
SERUM, HELICOBACTER, GASTRITIS, GASTROENTERITIS
Abstract

Abstract: Background.: Several tests have been proposed for evaluating dyspeptic symptoms and their relationship to the underlying gastric disease. Serum pepsinogens and gastrin-17 are known to be useful biomarkers for the detection of gastric pathologies. Aim.: To evaluate the capability of screening dyspeptic patients in the primary care by analyses of serum pepsinogens I (sPGI) and II (sPGII), gastrin-17 (sG-17) and the IgG anti-Helicobacter pylori antibodies (IgG-Hp). Patients and methods.: Three hundred and sixty-two consecutive patients with dyspeptic symptoms (208 females, mean age 50.6±16 years, range 18–88 years) referred by general practitioners for upper gastrointestinal endoscopy were enrolled. A blood sample was taken from each subject for IgG-Hp, sPGI, sPGII and sG-17 analyses. Results.: Two hundred and eighty-seven patients had a complete screening; of these, 132 resulted positive for Hp infection. Patients with atrophic chronic gastritis showed significantly lower serum pepsinogen I levels and sPGI/sPGII ratio than patients with non-atrophic chronic gastritis. Moreover, by calculating the values of sPGI by sG-17 and sG-17 by sPGII/sPGI, subjects with atrophic chronic gastritis could be distinguished from those with non-atrophic chronic gastritis and from those with normal mucosa, respectively. sG-17 levels were found to be a useful biomarker for the detection of antral atrophic gastritis, while the combination of sPGI, the sPGI/sPGII ratio and sG-17 was found effective in identifying corpus atrophy. Conclusion.: A panel composed of PGI, PGII, G-17 and IgG-Hp could be used as a first approach in the ‘test and scope’ and/or ‘test and treat’ strategy in the primary care management of dyspeptic patients. [Copyright &y& Elsevier]

Published
2005
Full Text
View/download PDF

Catalog

Books, media, physical & digital resources
See catalog results